Vantas

Vantas is a brand name of histrelin, approved by the FDA in the following formulation(s):

VANTAS (histrelin acetate - implant; subcutaneous)

• 
  Manufacturer: ENDO PHARM
  
  Approval date: October 12, 2004
  
  Strength(s): 50MG ^[RLD]

Has a generic version of Vantas been approved?

No. There is currently no therapeutically equivalent version of Vantas available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vantas. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Vantas.

See also...

• Vantas Consumer Information (Drugs.com)
• Vantas Implant Consumer Information (Wolters Kluwer)
• Vantas implant Consumer Information (Cerner Multum)
• Vantas Advanced Consumer Information (Micromedex)
• Vantas AHFS DI Monographs (ASHP)
• Supprelin-LA Consumer Information (Drugs.com)
• Histrelin Implant Consumer Information (Wolters Kluwer)
• Histrelin implant Consumer Information (Cerner Multum)
• Histrelin Subcutaneous Advanced Consumer Information (Micromedex)
• Histrelin acetate Subcutaneous Advanced Consumer Information (Micromedex)
• Histrelin AHFS DI Monographs (ASHP)